Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jul
6
2016
Apotex—Biosimilars Must Provide 180-Day Marketing Notice After FDA Approval Morgan, Lewis & Bockius LLP
Jun
2
2014
Visa Unavailability in EB-3 China Category Implemented by U.S. State Department Morgan, Lewis & Bockius LLP
Feb
28
2017
Highest Patent Court Narrows Scope of Covered Business Review Morgan, Lewis & Bockius LLP
Oct
8
2014
The Copyright Compendium: Public Draft Now Available Morgan, Lewis & Bockius LLP
May
23
2017
US Supreme Court Clarifies Where Corporations Can Be Sued for Patent Infringement Morgan, Lewis & Bockius LLP
Jan
22
2015
Supreme Court’s Trademark Tacking Decision: Possible Impact on Likelihood of Confusion? Morgan, Lewis & Bockius LLP
Jun
9
2011
Supreme Court Leaves Standard for Patent Invalidity Unchanged Morgan, Lewis & Bockius LLP
Sep
12
2011
Congress Passes America Invents Act Morgan, Lewis & Bockius LLP
Dec
21
2017
Federal Circuit Clarifies Akamai Standard for Divided Infringement Morgan, Lewis & Bockius LLP
Oct
14
2015
Consideration of Fair Use Before Sending a DMCA Takedown Morgan, Lewis & Bockius LLP
Apr
29
2014
Supreme Court Sets New Standard for Attorney Fee Recovery in Patent Cases Morgan, Lewis & Bockius LLP
Nov
29
2016
“Who’s on First?” Routine in Broadway Play Strikes Out as Transformative Fair Use Morgan, Lewis & Bockius LLP
Jun
14
2017
Humira Patents Invalidated in Inter Partes Reviews Morgan, Lewis & Bockius LLP
Nov
17
2017
Artificial Intelligence: Expectations of the IT Department Morgan, Lewis & Bockius LLP
Dec
30
2015
Contract Corner: Drafting to Protect Your IP Rights in Licensor’s Bankruptcy Morgan, Lewis & Bockius LLP
Mar
21
2014
Medical Device Update: FDA (Food and Drug Administration) Releases Final Pre-Submission Guidance Morgan, Lewis & Bockius LLP
May
18
2017
Federal Circuit Extends Prosecution Disclaimer to IPR Proceedings: Aylus Networks v. Apple Morgan, Lewis & Bockius LLP
Sep
12
2017
Transfer of Patents to Tribe May Preclude PTAB Scrutiny Morgan, Lewis & Bockius LLP
Sep
18
2017
Delaware Chief Judge Issues Guidelines for Venue in Patent Cases Morgan, Lewis & Bockius LLP
Sep
22
2017
Federal Circuit Clarifies Venue Law in the Wake of TC Heartland Morgan, Lewis & Bockius LLP
Jun
16
2011
The Federal Circuit Affirms the Delaware District Court’s Summary Judgment of Invalidity for Failure to Disclose the Best Mode Morgan, Lewis & Bockius LLP
Oct
26
2017
Residuals Clauses in IP Agreements and NDAs Morgan, Lewis & Bockius LLP
Feb
20
2012
Massachusetts Regulations to Protect Consumer Personal Information Contain March 1, 2012 Deadline. -Data Privacy Update Morgan, Lewis & Bockius LLP
Apr
30
2012
Court Ruling Allows Presentation of New Evidence in Civil Action Morgan, Lewis & Bockius LLP
Aug
10
2012
Private Challenges to Reverse Payment Settlement Allowed to Go Forward Morgan, Lewis & Bockius LLP
Sep
16
2012
ICO Guidance on Deleting Personal Data Under the Data Protection Act Morgan, Lewis & Bockius LLP
Oct
8
2012
Retail Did You Know? Court of Appeals Expands Inducement for Patent Infringeme​nt Morgan, Lewis & Bockius LLP
Mar
23
2016
Federal Circuit Tosses PTAB Decision: Dell v. Acceleron Morgan, Lewis & Bockius LLP
Jun
13
2016
Supreme Court Rejects Federal Circuit’s Two-Part “Objective Recklessness” Test Morgan, Lewis & Bockius LLP
Apr
20
2011
Updates on Transfers in the Eastern District of Texas Morgan, Lewis & Bockius LLP
Apr
29
2015
The High Price of Challenging a Refusal to Register a Trademark in District Court Morgan, Lewis & Bockius LLP
Jun
17
2011
Federal Circuit Changes Law for Post-Injunction Contempt Proceedings Against Modified Products Morgan, Lewis & Bockius LLP
Oct
6
2017
In IPRs, Petitioner Must Show Claim Amendments Unpatentable Morgan, Lewis & Bockius LLP
Oct
26
2017
Lawsuits Filed on the Same Day Regarding Amgen’s Avastin® Biosimilar Morgan, Lewis & Bockius LLP
Jun
23
2015
FTC Issues Updated Guidance on Endorsements Compliance - Federal Trademark Commission Morgan, Lewis & Bockius LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins